img

Global Bi-Specific Antibodies Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Bi-Specific Antibodies Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

A bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.
Bi-Specific Antibodies report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Bi-Specific Antibodies market is projected to reach US$ 4147.6 million in 2034, increasing from US$ 3266 million in 2022, with the CAGR of 3.4% during the period of 2024 to 2034. Demand from Cancer and Haemophilia are the major drivers for the industry.
Global Bi-Specific Antibodies Therapy key players include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, etc. Global top five manufacturers hold a share over 95%.
North America is the largest market, with a share about 65%, followed by Europe and China, both have a share over 30 percent. In terms of product, IgG-Based Antibodies is the largest segment, with a share over 85%. And in terms of application, the largest application is Haemophilia, followed by Cancer, etc.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Bi-Specific Antibodies market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Roche (Chugai)
Amgen
Segment by Type
Fragment-Based Antibodies
IgG-Based Antibodies

Segment by Application


Cancer
Haemophilia
Other Non-Cancer Diseases
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Bi-Specific Antibodies market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Bi-Specific Antibodies introduction, etc. Bi-Specific Antibodies Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Bi-Specific Antibodies market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Bi-Specific Antibodies
1.1 Bi-Specific Antibodies Market Overview
1.1.1 Bi-Specific Antibodies Product Scope
1.1.2 Bi-Specific Antibodies Market Status and Outlook
1.2 Global Bi-Specific Antibodies Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Bi-Specific Antibodies Market Size by Region (2024-2034)
1.4 Global Bi-Specific Antibodies Historic Market Size by Region (2024-2024)
1.5 Global Bi-Specific Antibodies Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Bi-Specific Antibodies Market Size (2024-2034)
1.6.1 North America Bi-Specific Antibodies Market Size (2024-2034)
1.6.2 Europe Bi-Specific Antibodies Market Size (2024-2034)
1.6.3 Asia-Pacific Bi-Specific Antibodies Market Size (2024-2034)
1.6.4 Latin America Bi-Specific Antibodies Market Size (2024-2034)
1.6.5 Middle East & Africa Bi-Specific Antibodies Market Size (2024-2034)
2 Bi-Specific Antibodies Market by Type
2.1 Introduction
2.1.1 Fragment-Based Antibodies
2.1.2 IgG-Based Antibodies
2.2 Global Bi-Specific Antibodies Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Bi-Specific Antibodies Historic Market Size by Type (2024-2024)
2.2.2 Global Bi-Specific Antibodies Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Bi-Specific Antibodies Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Bi-Specific Antibodies Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Bi-Specific Antibodies Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Bi-Specific Antibodies Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Bi-Specific Antibodies Revenue Breakdown by Type (2024-2034)
3 Bi-Specific Antibodies Market Overview by Application
3.1 Introduction
3.1.1 Cancer
3.1.2 Haemophilia
3.1.3 Other Non-Cancer Diseases
3.2 Global Bi-Specific Antibodies Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Bi-Specific Antibodies Historic Market Size by Application (2024-2024)
3.2.2 Global Bi-Specific Antibodies Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Bi-Specific Antibodies Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Bi-Specific Antibodies Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Bi-Specific Antibodies Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Bi-Specific Antibodies Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Bi-Specific Antibodies Revenue Breakdown by Application (2024-2034)
4 Bi-Specific Antibodies Competition Analysis by Players
4.1 Global Bi-Specific Antibodies Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bi-Specific Antibodies as of 2022)
4.3 Date of Key Players Enter into Bi-Specific Antibodies Market
4.4 Global Top Players Bi-Specific Antibodies Headquarters and Area Served
4.5 Key Players Bi-Specific Antibodies Product Solution and Service
4.6 Competitive Status
4.6.1 Bi-Specific Antibodies Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Roche (Chugai)
5.1.1 Roche (Chugai) Profile
5.1.2 Roche (Chugai) Main Business
5.1.3 Roche (Chugai) Bi-Specific Antibodies Products, Services and Solutions
5.1.4 Roche (Chugai) Bi-Specific Antibodies Revenue (US$ Million) & (2024-2024)
5.1.5 Roche (Chugai) Recent Developments
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business
5.2.3 Amgen Bi-Specific Antibodies Products, Services and Solutions
5.2.4 Amgen Bi-Specific Antibodies Revenue (US$ Million) & (2024-2024)
5.2.5 Amgen Recent Developments
6 North America
6.1 North America Bi-Specific Antibodies Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Bi-Specific Antibodies Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Bi-Specific Antibodies Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Bi-Specific Antibodies Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Bi-Specific Antibodies Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Bi-Specific Antibodies Market Dynamics
11.1 Bi-Specific Antibodies Industry Trends
11.2 Bi-Specific Antibodies Market Drivers
11.3 Bi-Specific Antibodies Market Challenges
11.4 Bi-Specific Antibodies Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Bi-Specific Antibodies Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Bi-Specific Antibodies Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Bi-Specific Antibodies Market Size Share by Region (2024-2024)
Table 4. Global Bi-Specific Antibodies Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Bi-Specific Antibodies Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Bi-Specific Antibodies Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Bi-Specific Antibodies Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Bi-Specific Antibodies Revenue Market Share by Type (2024-2024)
Table 9. Global Bi-Specific Antibodies Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Bi-Specific Antibodies Revenue Market Share by Type (2024-2034)
Table 11. North America Bi-Specific Antibodies Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Bi-Specific Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Bi-Specific Antibodies Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Bi-Specific Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Bi-Specific Antibodies Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Bi-Specific Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Bi-Specific Antibodies Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Bi-Specific Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Bi-Specific Antibodies Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Bi-Specific Antibodies Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Bi-Specific Antibodies Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Bi-Specific Antibodies Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Bi-Specific Antibodies Revenue Market Share by Application (2024-2024)
Table 24. Global Bi-Specific Antibodies Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Bi-Specific Antibodies Revenue Market Share by Application (2024-2034)
Table 26. North America Bi-Specific Antibodies Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Bi-Specific Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Bi-Specific Antibodies Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Bi-Specific Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Bi-Specific Antibodies Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Bi-Specific Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Bi-Specific Antibodies Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Bi-Specific Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Bi-Specific Antibodies Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Bi-Specific Antibodies Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Bi-Specific Antibodies Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Bi-Specific Antibodies Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bi-Specific Antibodies as of 2022)
Table 39. Date of Key Players Enter into Bi-Specific Antibodies Market
Table 40. Global Bi-Specific Antibodies Key Players Headquarters and Area Served
Table 41. Bi-Specific Antibodies Product Solution and Service
Table 42. Global Bi-Specific Antibodies Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Roche (Chugai) Basic Information List
Table 45. Roche (Chugai) Description and Business Overview
Table 46. Roche (Chugai) Bi-Specific Antibodies Products, Services and Solutions
Table 47. Revenue (US$ Million) in Bi-Specific Antibodies Business of Roche (Chugai) (2024-2024)
Table 48. Roche (Chugai) Recent Developments
Table 49. Amgen Basic Information List
Table 50. Amgen Description and Business Overview
Table 51. Amgen Bi-Specific Antibodies Products, Services and Solutions
Table 52. Revenue (US$ Million) in Bi-Specific Antibodies Business of Amgen (2024-2024)
Table 53. Amgen Recent Developments
Table 54. North America Bi-Specific Antibodies Market Size by Country (2024-2024) & (US$ Million)
Table 55. North America Bi-Specific Antibodies Market Size by Country (2024-2034) & (US$ Million)
Table 56. Europe Bi-Specific Antibodies Market Size by Country (2024-2024) & (US$ Million)
Table 57. Europe Bi-Specific Antibodies Market Size by Country (2024-2034) & (US$ Million)
Table 58. Asia-Pacific Bi-Specific Antibodies Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 59. Asia-Pacific Bi-Specific Antibodies Market Size by Region (2024-2024) & (US$ Million)
Table 60. Asia-Pacific Bi-Specific Antibodies Market Size by Region (2024-2034) & (US$ Million)
Table 61. Asia-Pacific Bi-Specific Antibodies Market Share by Region (2024-2024)
Table 62. Asia-Pacific Bi-Specific Antibodies Market Share by Region (2024-2034)
Table 63. Latin America Bi-Specific Antibodies Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 64. Latin America Bi-Specific Antibodies Market Size by Country (2024-2024) & (US$ Million)
Table 65. Latin America Bi-Specific Antibodies Market Size by Country (2024-2034) & (US$ Million)
Table 66. Middle East & Africa Bi-Specific Antibodies Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 67. Middle East & Africa Bi-Specific Antibodies Market Size by Country (2024-2024) & (US$ Million)
Table 68. Middle East & Africa Bi-Specific Antibodies Market Size by Country (2024-2034) & (US$ Million)
Table 69. Bi-Specific Antibodies Market Trends
Table 70. Bi-Specific Antibodies Market Drivers
Table 71. Bi-Specific Antibodies Market Challenges
Table 72. Bi-Specific Antibodies Market Restraints
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bi-Specific Antibodies Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Bi-Specific Antibodies Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Bi-Specific Antibodies Market Share by Regions: 2022 VS 2034
Figure 4. Global Bi-Specific Antibodies Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Bi-Specific Antibodies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Bi-Specific Antibodies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Bi-Specific Antibodies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Bi-Specific Antibodies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Bi-Specific Antibodies Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Fragment-Based Antibodies
Figure 11. Global Fragment-Based Antibodies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of IgG-Based Antibodies
Figure 13. Global IgG-Based Antibodies Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Global Bi-Specific Antibodies Market Size Share by Type: 2022 & 2034
Figure 15. North America Bi-Specific Antibodies Revenue Market Share by Type (2024-2034)
Figure 16. Europe Bi-Specific Antibodies Revenue Market Share by Type (2024-2034)
Figure 17. Asia-Pacific Bi-Specific Antibodies Revenue Market Share by Type (2024-2034)
Figure 18. Latin America Bi-Specific Antibodies Revenue Market Share by Type (2024-2034)
Figure 19. Middle East and Africa Bi-Specific Antibodies Revenue Market Share by Type (2024-2034)
Figure 20. Cancer Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 21. Haemophilia Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 22. Other Non-Cancer Diseases Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 23. Global Bi-Specific Antibodies Market Size Share by Application: 2022 & 2034
Figure 24. North America Bi-Specific Antibodies Revenue Market Share by Application (2024-2034)
Figure 25. Europe Bi-Specific Antibodies Revenue Market Share by Application (2024-2034)
Figure 26. Asia-Pacific Bi-Specific Antibodies Revenue Market Share by Application (2024-2034)
Figure 27. Latin America Bi-Specific Antibodies Revenue Market Share by Application (2024-2034)
Figure 28. Middle East and Africa Bi-Specific Antibodies Revenue Market Share by Application (2024-2034)
Figure 29. Bi-Specific Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 30. Global Top 5 and Top 10 Players Bi-Specific Antibodies Market Share in 2022
Figure 31. North America Bi-Specific Antibodies Market Share by Country (2024-2034)
Figure 32. United States Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 33. Canada Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 34. Germany Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 35. France Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 36. U.K. Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 37. Italy Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 38. Russia Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 39. Nordic Countries Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 40. Asia-Pacific Bi-Specific Antibodies Market Share by Region (2024-2034)
Figure 41. China Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 42. Japan Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 43. South Korea Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 44. Southeast Asia Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 45. India Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 46. Australia Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 47. Latin America Bi-Specific Antibodies Market Share by Country (2024-2034)
Figure 48. Mexico Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 49. Brazil Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 50. Middle East & Africa Bi-Specific Antibodies Market Share by Country (2024-2034)
Figure 51. Turkey Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 52. Saudi Arabia Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 53. UAE Bi-Specific Antibodies Market Size (2024-2034) & (US$ Million)
Figure 54. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries